| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Kymera Therapeutics, Inc. | 10%+ Owner | Common Stock | 5,763,012 | $173,161,222 | $30.05 | 11 Aug 2021 | Indirect |
| Generation Bio Co. | 10%+ Owner | Common Stock | 608 | $1,161 | $1.91 | 29 Sep 2021 | Indirect |
| Generation Bio Co. | 10%+ Owner | Common Stock | 0 | $1.91 | 29 Sep 2021 | Direct | |
| Kymera Therapeutics, Inc. | 10%+ Owner | Common Stock | 0 | $30.05 | 11 Aug 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| GBIO | Generation Bio Co. | 27 Sep 2021 | 6 | -$2,059,519 | 4 | 10%+ Owner | 29 Sep 2021, 19:15 |
| GBIO | Generation Bio Co. | 22 Sep 2021 | 7 | -$3,511,993 | 4 | 10%+ Owner | 24 Sep 2021, 20:59 |
| KYMR | Kymera Therapeutics, Inc. | 11 Aug 2021 | 1 | -$14,770,113 | 4 | 10%+ Owner | 12 Aug 2021, 10:42 |
| GBIO | Generation Bio Co. | 24 Jun 2021 | 4 | -$801,618 | 4 | 10%+ Owner | 28 Jun 2021, 16:56 |
| GBIO | Generation Bio Co. | 21 Jun 2021 | 12 | -$4,635,967 | 4 | 10%+ Owner | 23 Jun 2021, 20:26 |